|
Embryonic
Stem Cell Procedure Did Not Work As Claimed
Another
Phony News Release Boosts American Cell Technology’s
Stock- Again. Hopes Of Sufferers Raised and
Dashed-Again.
FOR IMMEDIATE RELEASE
August 25, 2006
Worldwide
media reporting that embryonic stem cells have been
procured and grown without killing human embryos are
false.
Advanced Cell Technology (ACT) has misreported
the outcome of their study that appeared in the
science journal Nature.
ACT publicly claims
that they were able to take a single embryonic stem
cell out of 8-10 cell human embryos and grow embryonic
stem cells from those cells without killing the human
embryos. The
actual study in Nature says that ACT actually
removed 4-7 cells from each of the 16 embryos used and
that all of those embryos were destroyed.
Embryonic
stem cell research and reporting is increasingly
fraudulent.
Last year Science, a leading scientific
periodical, published peer reviewed claims of South
Korean researcher Hwang Woo-suk that he had cloned
human embryos and had developed human embryonic stem
cell lines from those cloned embryos.
Woo-suk’s claims were completely fabricated.
Embryonic
stem cell research is increasingly politicizing
science.
Even The New England Journal of Medicine
has
announced it will publish in the area of stem cell
research with an eye to impacting the political
debate. This
is inappropriate and diminishes The NEJM’s
reliability.
The
public should be wary about the always “potential”
claims of embryonic stem cell research.
After years of research and hundreds of
millions of federal and private dollars, there are no
human embryonic stem cell applications.
There are none in sight.
There are no human trials and investors are
running from it.
A recent New York Times story says that
embryonic stem cell researchers are backing off their
therapeteutic claims that these type of stem cells
will have any therapeutic value.
These researchers are now claiming that
embryonic stem cells will be good for “basic
research.”
This is scandalous because researchers and
embryonic stem cell politicians have played to and
upon the hopes of sufferers to gain federal funding to
support their research ventures as well as gaining
votes. It
is scandalous because adult (non-embryonic) stem cell
research has provided benefits for many of the
diseases that embryonic stem cell proponents say can
only be cured by embryonic stem cell research.
ACT’s
stock has fallen dramatically in the last year.
ACT’s stock rose over 400 percent with the
false announcement.
But this is not unusual.
Several years ago ACT generating publicity and
investment when it announced wrongly that it had
created the first human cloned embryos.
###
|
